Gen.Orph Overview
- Founded
- 2012
- Status
- Private
- Latest Deal Type
- Early Stage VC
- Investors
- 1
Gen.Orph General Information
Description
Producer of generic orphan drugs designed to treat rare diseases. The company's drugs aims at providing patients and medical teams worldwide with generic orphan drugs that are affordable and effective to cure rare diseases as well as drugs that are neglected by the pharmaceutical industry although they are still medically useful, enabling patients to get treatment at an affordable price
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- 1 rue royale
- 92210 Saint-Cloud
- France
+33 01 00 00 00 00
Gen.Orph Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-2014 | Completed | Generating Revenue |
Gen.Orph Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Etienne Jacob | Chief Executive Officer & Co-Founder | ||
| Eric Lille | Chief Financial Officer | ||
| Patrice Layrac | Director & Co-Founder |
Gen.Orph Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Crédit Mutuel Innovation | Venture Capital | Minority | 000 0000 | 000000 0 |